|
|||
|
Multiple Sclerosis Info
|
Friday, March 28
by
multiplesclerosis
on Fri 28 Mar 2008 12:00 AM CST
Inflammation-induced oxidative stress can lead to axonal degeneration, which is felt to be a major determinant of progressive neurological disability in Multiple Sclerosis (MS). more »
Monday, March 24
by
multiplesclerosis
on Mon 24 Mar 2008 03:10 PM CST
Regulatory T cells, which function like immune system police, learn early in life what to protect, and that may include viruses, bacteria, and tumours, more »
Thursday, March 20
by
multiplesclerosis
on Thu 20 Mar 2008 01:00 AM CST
OBJECTIVE :
To determine if task performance and fatigability during rapid repetitive exercise of the lower limb differ in a group of MS subjects compared to a control group, and what central changes accompany more »
by
multiplesclerosis
on Thu 20 Mar 2008 12:00 AM CST
This study was concerned with examining relation between anxiety, depression, and locus of control (LC) in Croatian multiple sclerosis (MS) patients in order to more »
Monday, March 17
by
multiplesclerosis
on Mon 17 Mar 2008 07:52 AM CST
Our objective was to demonstrate the efficacy and impact on quality of life of detrusor (muscle of the bladder) injections of botulinum neurotoxin type A in the treatment of bladder more »
Monday, March 10
by
multiplesclerosis
on Mon 10 Mar 2008 12:00 AM CST
A prospective 12-week follow-up study after relapse was conducted among 14 multiple sclerosis (MS) patients treated with oral high-dose (1 g) methylprednisolone for 3 days more »
Saturday, March 8
by
multiplesclerosis
on Sat 08 Mar 2008 07:56 AM CST
Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain
Treatment of neuropathic pain, triggered by multiple insults to the ... more » Tuesday, March 4
by
multiplesclerosis
on Tue 04 Mar 2008 12:00 AM CST
Pseudobulbar affect (PBA) is defined as episodes of involuntary crying, laughing, or both in the absence of a matching subjective mood state. This neuropsychiatric syndrome can be found in more »
Monday, March 3
by
multiplesclerosis
on Mon 03 Mar 2008 02:00 AM CST
An international research team, led by a scientist from the Centre hospitalier de l'Université de Montréal (CHUM), has identified new therapeutic targets for the treatment of multiple sclerosis (MS). more »
Sunday, March 2
by
multiplesclerosis
on Sun 02 Mar 2008 09:21 AM CST
The new findings may partly explain why some patients respond to a particular treatment and others do not," says Claudia Lucchinetti, M.D., Mayo Clinic neurologist and the paper's senior and corresponding author. "The biological basis more »
|
||